Increased levels of parathyroid hormone, whether in primary or secondary hyperparathyroidism, disrupt normal calcium metabolism, leading to bone demineralization, hypercalcemia, and associated clinical manifestations. Management of hyperparathyroidism typically involves addressing the underlying cause, surgical removal of abnormal parathyroid tissue (in primary hyperparathyroidism), and medications to regulate calcium and PTH levels… Read More »